Webinar: How to develop your Cell Therapy manufacturing process

How do you translate your Cell Therapy processes to GMP? What are the challenges of bringing an iPSC-based therapy to the patient? How to set up a CAR-T manufacturing process?

On Wednesday 14 December we will explore the challenges one may face in establishing a Cell Therapy process for application in clinical trials. During this webinar, Melissa van Pel, head of Cell Therapy at NecstGen, will discuss two exemplary cell therapy types:

1) Induced pluripotent stem cell therapy (iPSC), a relatively new type of Cell Therapy that is regarded as one of the most promising solutions in regenerative medicine.

2) Chimeric antigen receptor T-cell therapy (CAR-T), a well established type of Cell Therapy that has faced commercial and clinical success, as well as logistical challenges as it matures.

We look forward to welcoming you to this online seminar.

Agenda

• 16:00hr – Welcome – Tristan Pritchard-Meaker (Head of Business Development, NecstGen)
• 16:05hr – How to set up your Cell Therapy process – Melissa van Pel (Head of Cell Therapy, NecstGen)
• 16:40hr – Interactive Q&A session

Date and time

• Wednesday, December 14, 2022, 4:00 PM – 4:45 PM CET

Location

• Online